Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-16 14:59 |
Compugen to Receive Milestone Payment Triggered by AstraZeneca’s Phase 2 Initia…
|
English | 74.7 KB | ||
| 2022-11-16 14:59 |
Compugen to Receive Milestone Payment Triggered by AstraZeneca’s Phase 2 Initia…
|
English | 36.0 KB | ||
| 2022-11-14 14:59 |
6K: Third Quarter 2022 Results
|
English | 87.0 KB | ||
| 2022-11-14 14:59 |
6K: Third Quarter 2022 Results
|
English | 35.9 KB | ||
| 2022-11-08 14:59 |
Compugen to Participate in the Stifel Healthcare Conference
|
English | 81.8 KB | ||
| 2022-11-08 14:59 |
Compugen to Participate in the Stifel Healthcare Conference
|
English | 36.0 KB | ||
| 2022-11-07 15:59 |
publication of the abstract on data demonstrating that anti-tumor activity foll…
|
English | 87.8 KB | ||
| 2022-11-07 15:59 |
publication of the abstract on data demonstrating that anti-tumor activity foll…
|
English | 35.9 KB | ||
| 2022-11-02 13:59 |
Compugen Announces Receipt of Nasdaq Delisting Notice
|
English | 71.1 KB | ||
| 2022-11-02 13:59 |
Compugen Announces Receipt of Nasdaq Delisting Notice
|
English | 36.0 KB | ||
| 2022-10-31 13:59 |
Compugen to Release Third Quarter 2022 Results on Monday, November 14, 2022
|
English | 93.4 KB | ||
| 2022-10-31 13:59 |
Compugen to Release Third Quarter 2022 Results on Monday, November 14, 2022
|
English | 36.0 KB | ||
| 2022-10-26 15:59 |
Compugen to Present New Clinical Data at ESMO-IO
|
English | 100.8 KB | ||
| 2022-10-26 15:59 |
Compugen to Present New Clinical Data at ESMO-IO
|
English | 36.0 KB | ||
| 2022-10-06 15:59 |
Compugen to Present New Clinical and Research Data in Two Oral Presentations at…
|
English | 99.9 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
